Global Single Cell Multiomics Industry to 2027


DUBLIN, March 9, 2022 /PRNewswire/ — The Worldwide Single Cell Multiomics Industry report has been added to from offer.

The Global Single-Cell Multiomics Market Reached A Value Of US$2.85 billion in 2021. Looking ahead, the publisher expects the market to reach US$7.73 billion by 2027, posting a CAGR of 17.30% over the period 2022-2027. Keeping in mind the uncertainties of COVID-19, they continuously monitor and assess the direct and indirect influence of the pandemic on different end-use sectors. This information is included in the report as a major market contributor

Single-cell multiomics refers to the analysis of multiple types of molecules from an individual cell to better understand cellular diversity and heterogeneity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single-cell multiomics helps improve understanding of population architectures and cellular properties of heterogeneous tissues. It uses single cell isolation and distribution techniques to provide images of molecular layers and complex biological structures. Compared to traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of molecules from a single cell. Accordingly, it is widely used in biotechnology and pharmaceutical organizations, hospitals, universities and research institutes and diagnostic laboratories.

Single Cell Multiomics Market Trends:

The rising prevalence of chronic diseases, such as cancer and viral communicable diseases, is one of the major factors driving the growth of the market. Single-cell multiomics provides a high-resolution landscape of cellular components in tumors. Additionally, the widespread adoption of products for visualization and analysis of cellular heterogeneity, tumor microenvironment, and antibody development is driving the market growth.

Additionally, various technological advancements, such as the development of single-cell isolation and barcoding technologies that allow measurement of deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA), and protein profiles at single-cell resolution , give impetus to the growth of the market. In this light, the significant growth of the pharmaceutical industry has a positive impact on the growth of the market. Other factors including the increasing adoption of personalized medicine for the treatment of genetic diseases, along with tremendous improvements in healthcare infrastructure, are expected to drive the market towards growth.

Key Market Segmentation:

The publisher provides an analysis of the main trends in each sub-segment of the global single-cell multiomics market, as well as forecasts at the global, regional and country levels from 2022 to 2027. Our report has categorized the market based on type, type, type of product, technique, application and end user

Breakdown by type:

  • Single cell genomics
  • Single cell proteomics
  • Single cell transcriptomics
  • Single cell metabolomics

Breakdown by product type:

  • Consumables
  • Instruments
  • Software

Break by technique:

  • Single-cell isolation and distribution
  • Single cell analysis

Breakdown by application:

  • Oncology
  • cellular biology
  • Neurology
  • Others

Breakdown by end user:

  • University institutes
  • Contract research organizations
  • Pharmaceutical and biotechnology companies

Breakdown by region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been reviewed along with the profiles of major players namely 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings), and Thermo Fisher Scientific Inc. .

Answers to key questions in this report:

  • How has the global single-cell multiomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Global Single Cell Multiomics Market?
  • What are the main regional markets?
  • What is the market breakdown by type?
  • What is the market breakdown by product type?
  • What is the breakout of the market based on the technique?
  • What is the market breakdown by application?
  • What is the market breakdown by end user?
  • What are the different stages of the industry value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global single-cell multiomics market and who are the key players?
  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive Summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Single Cell Multiomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakdown by Type
6.1 Single-cell genomics
6.1.1 Market trends
6.1.2 Market Forecast
6.2 Single-cell proteomics
6.2.1 Market trends
6.2.2 Market Forecast
6.3 Single-cell transcriptomics
6.3.1 Market trends
6.3.2 Market Forecast
6.4 Single cell metabolomics
6.4.1 Market trends
6.4.2 Market Forecast

7 Market Breakdown by Product Type
7.1 Consumables
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Instruments
7.2.1 Market trends
7.2.2 Market Forecast
7.3 Software
7.3.1 Market trends
7.3.2 Market Forecast

8 Market Breakdown by Technique
8.1 Single cell isolation and distribution
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Single cell analysis
8.2.1 Market trends
8.2.2 Market Forecast

9 Market Breakdown by Application
9.1 Oncology
9.1.1 Market trends
9.1.2 Market Forecast
9.2 Cell biology
9.2.1 Market trends
9.2.2 Market Forecast
9.3 Neurology
9.3.1 Market trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market trends
9.4.2 Market Forecast

10 Market Breakdown by End User
10.1 University institutes
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Contract research organizations
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical and biotechnology companies
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakdown by Region

12 SWOT Analysis

13 Value chain analysis

14 Analysis of the five forces of carriers

15 Price Analysis

16 Competitive Landscape
16.1 Market structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 10x Genomics Inc. Company Overview Product portfolio Finance
16.3.2 Becton Dickinson and Company Presentation of the company Product portfolio Finance SWOT Analysis
16.3.3 BGI Genomics (BGI Group) Company Overview Product Portfolio Finance
16.3.4 Bio-RAD Laboratories Inc. Company Overview Product portfolio Finance SWOT Analysis
16.3.5 Fluidigm Company Company Overview Product portfolio Finance
16.3.6 Illumina Inc. Company Overview Product portfolio Finance SWOT Analysis
16.3.7 Mission Bio Company Overview Product portfolio
16.3.8 NanoCellect Biomedical Company Overview Product portfolio
16.3.9 Nanostring Technologies Inc. Company Overview Product portfolio Finance
16.3.10 Proteona Company Overview Product portfolio
16.3.11 Takara Bio Inc. (Takara Holdings) Company Overview Product portfolio Finance
16.3.12 Thermo Fisher Scientific Inc. Company Overview Product portfolio Finance SWOT Analysis

For more information on this report visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets


Comments are closed.